Read the Full Article for Free! You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access Unlock censored health information that Google doesn’t want you to read Keep your privacy secure — we… Read More »
After scoring an early authorization for its COVID-19 therapy remdesivir, Gilead Sciences has been on the hunt for manufacturing partners to help boost production. Through a series of licensing agreements with generics makers, Gilead has taken the first steps to build that network. Gilead signed nonexclusive licensing agreements with five generic drug makers operating in India and… Read More »
Remdesivir, an antiviral drug designed to treat both hepatitis and a common respiratory virus, seemed fated to join thousands of other failed medications after proving useless against those diseases. The drug was consigned to the pharmaceutical scrap heap, all but forgotten by the scientists who once championed it. But on Friday, the Food and Drug… Read More »
What your doctor is reading on Medscape.com: APRIL 24, 2020 — As the COVID-19 pandemic continues, efforts to identify a safe and effective therapy have intensified, leading to this week’s top trending clinical topic. New data on the investigational antiviral drug remdesivir were published April 10 in the New England Journal of Medicine . More than two thirds of… Read More »